Psoriatic Arthritis
The MD Magazine Psoriatic Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Two Drugs Top Global Sales List
Global drug sales will reach nearly $1 trillion by 2020, a new report predicts. In 2014 the top sellers were the rheumatoid arthritis drug Humira and the hepatitis C anti-viral Sovaldi.
More than 70,000 patients participated in a clinical trial designed to determine the hazard risk of developing psoriatic arthritis (PsA) following physical trauma in patients with psoriasis.
The novel drug ixekizumab has been found to clear psoriasis symptoms, according to results from a clinical trial led by researchers from the University of Manchester.
Is the prevalence of undiagnosed PsA high enough to recommend dermatologists and other clinicians who treat patients with psoriasis to also screen those patients for psoriatic arthritis?
Researchers have identified a set of rules that determine which molecules can trigger immune system vulnerability to common autoimmune disorders like lupus and psoriasis.
Among adults with one or more chronic conditions, those with arthritis appear much more likely than those without arthritis to have work disability, according to research published in the June 5 issue of the US Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Plasma-rich platelet injection, an arthritis therapy, is thought to induce regeneration of damaged cartilage. A Netherlands team looked at existing studies and was not convinced that there is credible proof the therapy works. The studies all had a high-to-moderate risk of bias, they found.

Most Popular

$vacMongoViewPlus$ $vAR$